Delta-Fly Pharma (4598) · InitiativeRestated
Considering clinical trials in regions with high execution feasibility
First written in FY2024. 1 of 2 entries say "Restated". Latest entry: FY2026.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Considering clinical trials in regions with high execution feasibilityA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2026RestatedAnnual report
「Taking into account the status of clinical-trial sites in Japan and the United States, we will consider and implement clinical trials in regions with a high likelihood of execution.」
臨床試験への影響が生じた場合、治験施設の状況を踏まえて実行可能性の高い地域を選ぶ対応策を再確認している。 - FY2024First statedAnnual report
「Taking into account the status of clinical-trial sites in Japan and the United States, we will consider and implement clinical trials in regions with a high likelihood of execution.」
地政学的リスク等で日米の臨床試験に影響が及ぶ場合に、治験施設の状況を踏まえて実行可能性の高い地域を選ぶ対応策が初めて示された。